CRISPR Therapeutics stock pops following disclosure of RFK Jr. investment
- An investment disclosure form provided by President Donald Trump’s nominee to be the next HHS Secretary, Robert F. Kennedy Jr., revealed he has investments in several stocks, including CRISPR Therapeutics (NASDAQ:CRSP).
- The revelation caused the stock’s share price to spike 10% at